Global Malaria Vaccines Market: Overview
The prevalence of malaria in tropical countries has been troublesome to the entire world, contributing to millions of deaths over the last ten years. Vaccine development forms a crucial part of adequate interventional control. Recent years have seen considerable research on novel vaccine candidates. Supported by continuous research of malaria life-cycle, a diverse pipeline has been investigated. Understanding the biology of deadly human malaria parasites Plasmodium falciparum and Plasmodium vivax is key to growing avenues in the malaria vaccines market. Generations of pre-erythrocytic vaccines have unlocked new avenues in the malaria vaccines market. This has attracted a volley of investments from biotech companies. RTS,S/AS01 (RTS,S) is the most vigorously tested vaccine candidate for prevention of malaria caused by P. falciparum.
The study on the global malaria vaccines market takes a closer look at the investment trends related with different approached of vaccine development around the world. It provides a scrutiny on the efforts of healthcare systems to reduce the burden of malaria, especially in countries where it has grown to endemic proportions. It highlights key growth drivers and challenges to various stakeholders in vaccine development during the forecast period (2019 – 2027).
Global Malaria Vaccines Market: Key Trends
The report on the malaria vaccine market provides a granular assessment of key growth avenues for vaccine manufacturers, share and size of various segments, and projections of opportunities in these during the forecast period of 2019 – 2027. It takes a closer look at clinical testing of next-generation vaccine designs.
Over the past couple of years, researchers have been able to increase the vaccine-induced efficacy considerably. Spate of clinical trials have focused on improving RTS,S/AS01. Such developments were invigorated by recent trials sub-Saharan Africa. According to the WHO, RTS,S has been evaluated for use as a complementary malaria control tool to its preventive, diagnostic, and treatment measures. It is the only vaccine that has demonstrated its efficacy in reducing malaria, especially in young African children.
The growing number of routine immunization programs in various countries is boosting the malaria vaccines market. Over the past few years, The WHO has made coordinated efforts to promote public health use of the vaccine. The advent of novel adjuvants and cutting-edge vaccine delivery platforms are opening new avenues in the malaria vaccine market.
Global Malaria Vaccines Market: Geographical Analysis
Growing funding on vaccine development programs have made developed regions center of attention for players in malaria vaccines market. In this regard, the prospects in the malaria vaccines market are bolstered by a positive outlook of regulatory authorities in Europe. Growing number of phase 2 and 3 trials have seen lucrative avenues for vaccine manufacturers in Africa. Latin America has also seen the rapidly growing number of malaria cases. Further, North America is projected to be one of the most prominent regional markets. Asia Pacific is expected to be one of the promising regions for vaccine development.
Global Malaria Vaccines Market: Competitive Scenario
Key markets have scientists utilizing malaria research platforms. Pharmaceutical companies in these markets have made an array of recent investments. Companies who intend to put large stakes in the malaria vaccines market are carefully considering immunological and genetic considerations. New entrants are more likely to lay increased focus on cost-effectiveness of the recent vaccine candidates. Some of the well-entrenched players in the malaria vaccines market are Genome ReS Ltd., VLP Therapeutics LLC, Cadila Healthcare Ltd., CellFree Sciences Co. Ltd., Sanaria, GenVec, Inc., Nobelpharma, and GlaxoSmithKline.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.